Goal of antianginal therapy {Ans: Goal is reduction of myocardial O2 consumption (MVO2) by decreasing 1 or more of the determinants of MVO2: end-diastolic volume, BP, HR, contractility.}Galantamine {Ans: -Anticholinesterse - increases ACh -Alzheimer disease}ADH antagonist clinical use {Ans: SIADH, block action of ADH at V2-receptor.}Nonspecific stimulant withdrawal {Ans: post-use "crash," including depression, lethargy, weight gain, headache}Goals of infection control techniques {Ans: Goals include the reduction of pathogenic organism counts to safe levels (disinfection) and the inactivation of self-propagating biological entities (sterilization).}Cyclosporine toxicity {Ans: Nephrotoxicity, hypertension, hyperlipidemia, neurotoxicity, gingival hyperplasia, hirsutism.}